Company Profile
Profil emiten IDX — keuangan, direksi, komisaris, anak usaha
PT. Esa Medika Mandiri Tbk.
EMMI
Sector: -
Industry: -
Sub Sector: -
Sub Industry: -
Live quote
tidak tersedia
Highlight Keuangan (2026 Q2) (In Rp)
EPS
-34
ROE
-56,87%
ROA
-12,40%
Book Value
60
Net Income
-29,95 M
Total Sales
65,35 M
Total Assets
483,18 M
DER
3.52x
Struktur Pemegang Saham (>1%)
Free Float Information
Saham tersebar di publik
13,34%
SURYA GUNAWAN WIDJAJA 🔗
21,07%
Individual · Lokal
ANDREW IGNATIUS WIDJAJA 🔗
16,38%
Individual · Lokal
ANDRIAN MATTHEW WIDJAJA 🔗
11,20%
Individual · Lokal
FLORIAN CHRIS WIDJAJA 🔗
11,20%
Individual · Lokal
EDDY LIE 🔗
10,15%
Individual · Lokal
PT YULIE SEKURITAS INDONESIA TBK 🔗
9,30%
Securities Company · Lokal
HENDY FU 🔗
3,85%
Individual · Lokal
FIN CENTERINDO DUA, PT 🔗
1,17%
Peer To Peer Lending · Lokal
PT ASURANSI JIWA CENTRAL ASIA RAYA 🔗
1,17%
Insurance · Lokal
PT. JAYAKUSUMA PERDANA LINES 🔗
1,17%
Corporate · Lokal
Tentang Perusahaan
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Produk & Lini Bisnis
The scope of the Companys activities is in trading and human health activities and social activities. The Company are able to conduct wholesale trade activities of laboratory equipment, pharmaceuticals, and medical devices for humans, retail trade in laboratory equipment, pharmaceuticals, and medical devices for humans, health support service activities. Currently, the Company operates in wholesale trade activities of laboratory equipment and medical devices for humans.
Dewan Direksi
FC
Florian Chris Widjaja
President Director
EL
Eddy Lie
Director
JA
Jason Aaron Lie
Director
AM
Andrian Matthew Widjaja
Director
Dewan Komisaris
SG
Surya Gunawan Widjaja
President Commissioner
AI
Andrew Ignatius Widjaja
Commissioner
I
Iwanho
Independent Commissioner
SS
Sodikin Sadek
Independent Commissioner
Anak Usaha & Afiliasi
NamaDomisili%
PT. Med8 Makmur Mandiri
General trade, Construction (contractors), Services, Agencies, Representatives, Advertising, Transportation, Agriculture and industry
 Tangerang 55.00%
PT. Esa Behrindo Trijaya
Retail Trade and Wholesale Trade of Laboratory Equipment, Pharmaceutical Equipment and Medical Equipment for Humans
 Tangerang 60.00%
PT. Sonnen Utama Nasional
Retail Trade and Wholesale Trade of Laboratory Equipment, Pharmaceutical Equipment and Medical Equipment for Humans
 Tangerang 90.00%
Trend Keuangan (5 periode terakhir) — hover bar untuk detail
Total Sales Net Income (+) Net Income (-)
455jt 341jt 227jt 114jt 0 Sales 2023Q4: Rp 172.980.978 Net Income 2023Q4: Rp 939.421 2023Q4 Sales 2024Q4: Rp 384.934.998 Net Income 2024Q4: Rp 11.008.679 2024Q4 Sales 2025Q4: Rp 454.636.080 Net Income 2025Q4: Rp 34.132.251 2025Q4 Sales 2026Q2: Rp 65.345.044 Net Income 2026Q2: Rp -29.951.007 2026Q2
2023 Q4
EPS 2.314
ROE 1,85%
2024 Q4
EPS 27.115
ROE 17,77%
2025 Q4
EPS 56
ROE 25,23%
2026 Q2
EPS -34
ROE -56,87%
Laporan Keuangan Historis (5 Periode Terakhir) (In Rp)
PeriodeTotal SalesNet IncomeTotal AssetsTotal EquityEPSROEDER
2026 Q2 65,35 M -29,95 M 483,18 M 105,33 M -34 -56,87% 3.52x
2025 Q4 454,64 M 34,13 M 564,44 M 135,28 M 56 25,23% 3.10x
2024 Q4 384,93 M 11,01 M 714,39 M 61,95 M 27.115 17,77% 10.35x
2023 Q4 172,98 M 939,42 Jt 340,63 M 50,79 M 2.314 1,85% 5.60x
Trend Harga Penutupan & Book Value — hover titik untuk detail
Close Price Book Value
167,8K 125,9K 83,9K 42,0K 0 Book Value 2023Q4: Rp 125.090 2023Q4 Book Value 2024Q4: Rp 152.586 2024Q4 Book Value 2025Q4: Rp 222 2025Q4 Book Value 2026Q2: Rp 60 2026Q2
2023 Q4
Close -
BV 125.090
ROA 0,28%
2024 Q4
Close -
BV 152.586
ROA 1,54%
2025 Q4
Close -
BV 222
ROA 6,05%
2026 Q2
Close -
BV 60
ROA -12,40%
History Harga Penutupan & Book Value
TahunQrtClose Price (Rp)Book Value (Rp)ROA
2026 2 - 60 -12,40%
2025 4 - 222 6,05%
2024 4 - 152.586 1,54%
2023 4 - 125.090 0,28%
Data diperbarui pada: 2026-08-07 08:06:41